GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G&E Healthcare Co Ltd (XKRX:299480) » Definitions » Accounts Receivable

G&E Healthcare Co (XKRX:299480) Accounts Receivable : ₩0.00 Mil (As of . 20)


View and export this data going back to 2018. Start your Free Trial

What is G&E Healthcare Co Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. G&E Healthcare Co's accounts receivables for the quarter that ended in . 20 was ₩0.00 Mil.

Accounts receivable can be measured by Days Sales Outstanding.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. G&E Healthcare Co's Net-Net Working Capital per share for the quarter that ended in . 20 was ₩N/A.


G&E Healthcare Co Accounts Receivable Historical Data

The historical data trend for G&E Healthcare Co's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G&E Healthcare Co Accounts Receivable Chart

G&E Healthcare Co Annual Data
Trend
Accounts Receivable

G&E Healthcare Co Semi-Annual Data
Accounts Receivable

G&E Healthcare Co Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.


G&E Healthcare Co Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

G&E Healthcare Co's Days Sales Outstanding for the quarter that ended in . 20 is calculated as:

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), G&E Healthcare Co's accounts receivable are only considered to be worth 75% of book value:

G&E Healthcare Co's Net-Net Working Capital Per Share for the quarter that ended in . 20 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(+0.75 * +0.5 * -N/A
--)/0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.


G&E Healthcare Co Accounts Receivable Related Terms

Thank you for viewing the detailed overview of G&E Healthcare Co's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


G&E Healthcare Co (XKRX:299480) Business Description

Traded in Other Exchanges
N/A
Address
No. 92, Keji 5th Road, Annan District, Tainan, TWN, 70955
G&E Healthcare Co Ltd, formerly G&E Biotech Co Ltd is a biopharmaceutical company focused on the development and commercialization of novel botanical extraction technology and products. It offers a range of products that include Hepato Protective Agent (Hepanamin) which prevent and cure for acute and chronic hepatitis, fatty liver conditions and liver toxicity infections, Botanical Healthcare product, and Botanical Anti-aging cosmetics.

G&E Healthcare Co (XKRX:299480) Headlines

No Headlines